We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 151

Impact of the temporary agency workers directive on the healthcare sector
  • Mason Hayes & Curran
  • Ireland, USA
  • September 12 2011

HSE Management who engage agency workers to cover a short-term need, such as an upturn in hospital admissions, sickness, absence or maternity leave, should be aware of the potentially far-reaching consequences of the Temporary Agency Workers Directive (the “Directive”


User fees for generic drugs - what are the issues?
  • Sheppard Mullin Richter & Hampton LLP
  • Ireland, USA
  • August 30 2010

On August 9, 2010, the Food and Drug Administration ("FDA") published a notice announcing a public meeting to be held September 17, 2010, "to gather stakeholder input on the development of a generic drug user fee program."



Ingrid Bagby
  • Cadwalader Wickersham & Taft LLP


Marco Plankensteiner
  • Kramer Levin Naftalis & Frankel LLP


Madeleine McDonough
  • Shook Hardy & Bacon LLP

Tim Marshall
  • DLA Piper LLP

Suzanne L Rab
  • King & Spalding LLP